LEGO owner invests USD 40m in skin treatments from fish skin

Icelandic firm Kerecis, which is pioneering cellular therapies and tissue regeneration treatments based on fish skin, has been the target of a USD 100m investment round led by LEGO owner Kirkbi.


Kirkbi, the private holding and investment firm for the Kirk Kristiansen family, the owners of toy brick giant LEGO, has led a USD 100m round of investments in an Icelandic biotech firm, reports MedWatch’s sister media, KapitalWatch.

Using sustainably sourced fish skin and fatty acids, Kerecis develops medical products like cellular therapies and tissue regeneration/protection treatments. Following the investment round, in which Kirky itself injected USD 40m, Kerecis’s valuation has increased to USD 620m.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs